Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer

Condition:   Advanced Ovarian Cancer Intervention:   Drug: SC10914 Sponsor:   Jiangxi Qingfeng Pharmaceutical Co. Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials